IRIS
DEIANA, Giovanni Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.790
AS - Asia 2.844
EU - Europa 2.035
SA - Sud America 1.595
AF - Africa 83
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.364
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.697
BR - Brasile 1.423
SG - Singapore 1.136
CN - Cina 930
UA - Ucraina 599
FR - Francia 378
SE - Svezia 299
DE - Germania 262
HK - Hong Kong 243
VN - Vietnam 207
IT - Italia 143
FI - Finlandia 104
GB - Regno Unito 81
AR - Argentina 63
TR - Turchia 50
IN - India 43
MX - Messico 35
IQ - Iraq 34
RU - Federazione Russa 34
ZA - Sudafrica 31
BD - Bangladesh 29
VE - Venezuela 27
CA - Canada 25
UZ - Uzbekistan 24
EC - Ecuador 23
BE - Belgio 22
PL - Polonia 19
JP - Giappone 18
ES - Italia 17
ID - Indonesia 17
CO - Colombia 16
KR - Corea 16
MA - Marocco 16
NL - Olanda 15
CL - Cile 12
PK - Pakistan 12
AE - Emirati Arabi Uniti 11
LT - Lituania 11
PY - Paraguay 11
AT - Austria 10
NP - Nepal 10
CZ - Repubblica Ceca 9
DO - Repubblica Dominicana 9
JO - Giordania 9
PE - Perù 8
UY - Uruguay 8
AU - Australia 7
TN - Tunisia 7
AZ - Azerbaigian 6
HN - Honduras 6
IR - Iran 6
KE - Kenya 6
DZ - Algeria 5
EG - Egitto 5
IL - Israele 5
KZ - Kazakistan 5
NI - Nicaragua 5
OM - Oman 5
RO - Romania 5
BO - Bolivia 4
EU - Europa 4
GR - Grecia 4
PA - Panama 4
SY - Repubblica araba siriana 4
AL - Albania 3
BW - Botswana 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
GA - Gabon 3
HR - Croazia 3
LB - Libano 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PS - Palestinian Territory 3
RS - Serbia 3
SA - Arabia Saudita 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BH - Bahrain 2
CH - Svizzera 2
IE - Irlanda 2
ME - Montenegro 2
QA - Qatar 2
TT - Trinidad e Tobago 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BT - Bhutan 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
KW - Kuwait 1
Totale 11.358
Salva come PNG Salva come JPEG
Città #
Dallas 1.628
Singapore 564
Chandler 537
Jacksonville 373
San Jose 246
Hong Kong 241
Ashburn 188
Beijing 188
Princeton 185
Dearborn 162
Nanjing 152
São Paulo 116
Wilmington 93
Lauterbourg 87
Ho Chi Minh City 86
New York 81
Nanchang 69
Shanghai 63
Ann Arbor 60
Boardman 60
Los Angeles 53
Tianjin 42
Hebei 40
Hanoi 39
Shenyang 38
Woodbridge 36
Changsha 33
Rio de Janeiro 33
Belo Horizonte 32
Rome 27
Santa Clara 27
Jiaxing 26
Porto Alegre 25
Sassari 25
Brasília 23
Denver 23
Brussels 22
Baghdad 21
Buffalo 21
Campinas 21
Johannesburg 21
Tashkent 21
Curitiba 20
Munich 19
Jinan 18
Tokyo 17
Warsaw 17
Seoul 16
Bochum 15
Andover 14
Hangzhou 14
Orem 14
Da Nang 13
Ribeirão Preto 13
Salvador 13
Goiânia 12
Helsinki 12
London 12
Mexico City 12
San Francisco 12
Caxias do Sul 11
Dhaka 11
Guangzhou 11
Izmir 11
Kunming 11
Zhengzhou 11
Brooklyn 10
Guarulhos 10
Istanbul 10
Atlanta 9
Chennai 9
Duque de Caxias 9
Frankfurt am Main 9
Ipatinga 9
Montreal 9
Norwalk 9
Sorocaba 9
Toronto 9
Volta Redonda 9
Amman 8
Amsterdam 8
Bauru 8
Campo Grande 8
Canoas 8
Carapicuíba 8
Council Bluffs 8
Dubai 8
Florianópolis 8
Fortaleza 8
Guayaquil 8
Itajaí 8
Manchester 8
Mauá 8
Medellín 8
Montevideo 8
Ningbo 8
Poplar 8
São José dos Campos 8
Brno 7
Haiphong 7
Totale 6.443
Salva come PNG Salva come JPEG
Nome #
A liquid chromatography-mass spectrometry study on the spirocyclization of ninhydrin with the aminothiols 276
"Erratic" complex partial status epilepticus as a presenting feature of MELAS 206
Antibody response against HERV-W env surface peptides differentiates multiple sclerosis and neuromyelitis optica spectrum disorder 197
Risk of False Acetylcholine Receptor Autoantibody Positivity by Radioimmunoprecipitation Assay in Clinical Practice 192
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 191
Acute hyponatremia and neuroleptic malignant syndrome 180
Beneficial effect of risperidone on behavioral disturbances associated with hyperostosis frontalis interna 178
Herv-k modulates the immune response in als patients 178
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson's disease 173
Humoral immunity response to HERV-K/W differentiates between amyotrophic lateral sclerosis and other neurological diseases 170
A simple capillary electrophoresis method for the analysis of lamotrigine in serum 167
Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls 160
Carbamazepine therapy for steroid psychosis 159
Carbamazepine in delayed-onset cerebellar tremor 156
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 150
Brain intgerstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 149
Asterixis and mild encephalopathy induced by gabapentin 149
Focal and secondarily generalised convulsive status epilepticus induced by thiocolchicoside in the rat 148
Beneficial effect of fluoxetine in hyperekplexia 144
Brain interstitial fluid amino acids in pentylene-tetrazol-induced status eplilepticus 142
Brain interstitial fluid collected trhough implanted tissue cages 140
Reduced intravenous glutathione in the treatment of early Parkinson's disease 137
Hyperthermia, choreic dyskinesias and increased motor tone in Wernicke's encephalopathy 136
IDENTIFICATION OF POTENTIAL BIOMARKERS IN MYASTHENIA GRAVIS DISEASE BY PLASMA PROTEOMIC ANALYSIS 131
Carbamazepine in delayed-onset cerebellar tremor 130
Attività epilettogena del tiocolchicoside nell'uomo e nel ratto wistar 129
Brain interstitial fluid collected through implanted tissue cages 128
Acute hyponatremia and neuroleptic malignant syndrome in Parkinson’s Disease 128
Plasma vitronectin is reduced in patients with myasthenia gravis: Diagnostic and pathophysiological potential 126
Delayedonset cerebellar tremors (DOCT): natural history and treatment 124
Determination of L-alpha aminoadipic acid levels in human and experimental epilepsy 124
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 124
Carbamazepine, clonazepam and focal reflex proprioceptive seizures 121
Expressive aphasia exacerbated by lamotrigine and gabapentin 121
Epilepsy in definite multiple sclerosis (MS): comparison of two hospitalisation-based series in Sardinia 121
Neuroleptic maglignant syndrome and related syndromes in a neurological popupation 119
Tache Noire in a Patient with Acute Q Fever 118
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 116
Exploratory screening for Fabry's disease in young adults with cerebrovascular disorders in northern Sardinia 115
Excitatory amino acids in brain interstitial fluid during sustained pentylenetetrazole-induced seizures 115
Reduced intravenous glutathione in Parkinson's disease 113
Focal e secondarily generalized convulsive status epilepticus induced by thiocolchicoside in the rat 112
Detection of Chlamydia Pneumoniae In the CSF of Sardinian Patients With Multiple Sclerosis In The Presence Or Absence Of Oligoclonal Bands 111
Epilepsy in multiple sclerosis: Does AED resistances predict a worse outcome of disability? 110
Complex partial status epilepticus as presenting features of MELAS: Case report and review of literature 110
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazole-induced convulsive status epilepticus 109
Increase of alpha-aminoadipate in brain IF during PTZ-induced status epilepticus 107
Ceftriaxone for Alexander's Disease: A Four-Year Follow-Up 107
MuSK antibody-positive, seronegative myasthenia gravis in two sisters 106
Diagnostics of myasthenic syndromes: detection of anti-AChR and anti-MuSK antibodies 105
Intravenous glutathione in patients with Parkinson's disease 104
Siti di tremore "rubrale" 104
Post-ischemic cerebellar tremors and axonal sprouting in humans 103
Epileptogenic activity of thiocolchicoside 103
Urine bikunin as a marker of renal impairment in Fabry's disease 101
Ceruloplasmin and oxidative stress in multiple sclerosis 100
Cerebral and cerebellar diaschisis following carbamazepine therapy 100
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 99
Carbamazepine, clonazepam and focal reflex proprioceptives seizures 98
Ictus giovanile e Malattia di Fabry: lo stato dell’arte in Sardegna 98
Intrathecal overproduction of ceruloplasmin in patients with multiple sclerosis 97
Risperidone, neuroleptic malignant sindrome and probable dementia with Lewy bodies 96
Cytokines and multiple sclerosis severity: no correlation among Sardinians 96
Open study of the activity and tolerability of reduced intravenous glutathione in Parkinson's disease 96
Non-fluent speech in patients with partial epilepsy: Beneficial effect of levetiracetam 94
Detection of Chlamydia Pneumoniae in the CSF of Sardinian patients with multiple sclerosis in the presence or absence of oligoclonal bands 94
Epidemiology of seropositive myasthenia gravis in Sardinia: A population-based study in the district of Sassari 93
Levetiracetam in stiff-person syndrome 93
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients. 93
Preliminary experience with fluoxetine in primary focal dystonias 92
Complex partial status epilepticus as presenting feature of MELAS: case report and rewiew of literature 92
Co-variation of free amino acids in brain interstitial fluid during pentylenetetrazol-induced convulsive status epilepticus 92
Epilepsy in multiple sclerosis: does predict a worse outcome of disability? 90
Diaschisis, "Rossi -Effect", and antiepileptic action of carbamazepine 90
Encephalopathies related to antiepileptic drugs 89
Risperidone, neuroleptic malignant syndrome and probable dementia with Lewy bodies 89
In vitro treatments with ceftriaxone promote elimination of mutant glial fibrillary acidic protein and transcription down-regulation 87
Reduced intravenous glutathione in the treatment of early Parkinson’s Disease 87
Successful screening for Fabry disease in patients with juvenile stroke in North Sardinia 87
Neuroleptic malignant syndrome and sudden death after combined zuclopenthixol/trihexiphenidyl withdrawal 85
Pharmacology of delayed-onset cerebellar tremors 85
Chronic parkinsonism after use of diquat: clinical and MRI studies 85
Neuroleptic maglignant syndrome and related syndromes in a neurological population 84
Neurological disorders associated with Mycoplasma pneumoniae infection 84
Status epileptics induced by administration of thiocolchicoside to lithium-pretreated rats 84
Cerebrospinal fluid gamma-glutamyl transpeptidase in multiple sclerosis 84
Preclinical Models of Hepatocellular Carcinoma: Current Utility, Limitations, and Challenges 81
Non – fluent spech in patients with partial epilepsy: beneficial effect of levetiracetam 80
Delayed-onset cerebellar tremor after stroke 79
Pharmacology of delayed-onset cerebellar tremors 78
Glycosaminoglycans and fabry’s disease 77
Purification of an Acidic Polysaccharide with Anticoagulant Activity from the Marine Sponge Sarcotragus spinosulus 73
Discinesie bucco-linguali indotte dal fenobarbitale 72
Urinary trypsin inhibitor is a marker of renal disease in Fabry’s patients 72
Multiple sclerosis: correlation between cytokine production and disease progression in Sardinians 70
Familial autoimmune MuSK positive myasthenia gravis 69
Effetti avversi psichiatrici da steroidi e carbamazepina 67
Ceftriaxone has a therapeutic role in Alexander disease 66
Topiramate in patients with cerebellar tremor: a controlled trial 57
Neuroimaging leads to recognition of previously undiagnosed Fabry 46
Totale 11.393
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.182
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.182
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021242 0 0 0 0 0 0 0 0 0 146 54 42
2021/2022455 95 12 2 19 3 0 21 31 43 17 52 160
2022/20231.070 99 58 9 176 128 196 0 115 194 12 51 32
2023/2024320 54 41 10 8 80 21 2 20 9 7 26 42
2024/20252.834 71 13 177 55 145 68 210 531 1.020 355 104 85
2025/20264.076 175 1.071 772 593 335 243 497 117 187 86 0 0
Totale 11.435